TVG’s Rapid Share PredictorSM

Validated share predictions without the need to conduct primary marketing research

This exciting new tool provides instant access to patient share and share penetration (uptake) rates without the need to conduct primary marketing research, or the use of analogs. For quick assessments around new products such as acquisitions or licensing evaluations, etc., or, as another benchmark to validate your model, it delivers share estimates projected from your internal judgments about attributes.

The Rapid Share PredictorSM offers several advantages over analogs:

  • It is built on an analysis of proprietary historical primary research data drawn from over 7000 decision makers across more than 20 disease states, validated with over 80% accuracy
  • Allows you to focus on attribute variables rather than identifying and defending analog choices
  • Allows you to standardize forecasting methodology across products
  • Includes inputs from prescriber, patient and payor audiences, as well as proprietary response data from our parent company’s (PDI) expertise in sales force effectiveness
  • Offers a subscription service that allows you to choose your length of access and gain updated data on a regular basis.

A user-friendly simulator allows you to undertake and store “what if” analyses to assess different possible scenarios

The Rapid Share Predictor

 

Contact Us

For more information about TVG’s forecasting services contact:

Don Marshall
215-283-5435
dmarshall@tvg-inc.com